Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Diencephalic syndrome (DS) is a rare condition characterized by profound emaciation and failure to thrive (with normal caloric intake and normal linear growth), hyperalertness, hyperkinesias and euphoria, in the presence of hypothalamic tumors.
Biomarker and diagnostic research for diencephalic syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
76 publications have been identified in PubMed for diencephalic syndrome. Research spans Case Report / Case Series (34%), Review / Meta-Analysis (17%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 26 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:29 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
13 |
17% |
Laboratory research | 13 | 17% |
Clinical study results | 8 | 11% |
Disease patterns and progression | 8 | 11% |
Other research | 4 | 5% |
Testing and diagnosis research | 3 | 4% |
New treatment approaches | 1 | 1% |
Tobar M (2026). [PMID: 42098940](https://pubmed.ncbi.nlm.nih.gov/42098940/). *Am J Med Genet A*. [Clinical Trial Publication]
Toledano H (2026). [PMID: 41846387](https://pubmed.ncbi.nlm.nih.gov/41846387/). *Pediatr Blood Cancer*. [Clinical Trial Publication]
Naphade PU (2026). [PMID: 41656490](https://pubmed.ncbi.nlm.nih.gov/41656490/). *Ann Afr Med*. [Case Report / Case Series]
Giabicani E (2026). [PMID: 40827087](https://pubmed.ncbi.nlm.nih.gov/40827087/). *J Clin Endocrinol Metab*. [Clinical Trial Publication]
Ruggiero A (2026). [PMID: 41749521](https://pubmed.ncbi.nlm.nih.gov/41749521/). *Children (Basel)*. [Review / Meta-Analysis]
Panzo N (2026). [PMID: 41640498](https://pubmed.ncbi.nlm.nih.gov/41640498/). *Neuroophthalmology*. [Case Report / Case Series]
Zhang L (2026). [PMID: 41918381](https://pubmed.ncbi.nlm.nih.gov/41918381/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Basic Science / Preclinical]
Perriere A (2026). [PMID: 41697933](https://pubmed.ncbi.nlm.nih.gov/41697933/). *Horm Res Paediatr*. [Clinical Trial Publication]
Skaf K (2026). [PMID: 41727682](https://pubmed.ncbi.nlm.nih.gov/41727682/). *Front Endocrinol (Lausanne)*. [Clinical Trial Publication]
Gallardo V (2026). [PMID: 42001697](https://pubmed.ncbi.nlm.nih.gov/42001697/). *Growth Horm IGF Res*. [Review / Meta-Analysis]